{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:00:42Z","timestamp":1776337242908,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejso.2018.03.032","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T02:29:13Z","timestamp":1523500153000},"page":"1105-1111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification"],"prefix":"10.1016","volume":"44","author":[{"given":"Aditi","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suniti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal","family":"Bhandare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanket","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2018.03.032_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31818eec64","article-title":"Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"249","author":"Baratti","year":"2009","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.ejso.2018.03.032_bib2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","article-title":"Disseminated peritoneal adenomucinosis and Peritoneal mucinous adenocarcinoma: A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to pseudomyxoma peritonei","volume":"19","author":"Ronnett","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2018.03.032_bib3","series-title":"WHO classification of tumors of the digestive system","first-page":"122","article-title":"Adenocarcinoma of the appendix","author":"Carr","year":"2010"},{"issue":"1","key":"10.1016\/j.ejso.2018.03.032_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2018.03.032_bib5","series-title":"AJCC cancer staging manual","year":"2017"},{"issue":"10","key":"10.1016\/j.ejso.2018.03.032_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5858\/arpa.2011-0034-RA","article-title":"Mucinous neoplasms of the appendix and peritoneum","volume":"135","author":"Panarelli","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.ejso.2018.03.032_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0035-1564433","article-title":"Management of appendix cancer","volume":"28","author":"Kelly","year":"2015","journal-title":"Clin Colon Rectal Surg"},{"issue":"6","key":"10.1016\/j.ejso.2018.03.032_bib8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","article-title":"The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei","volume":"71","author":"Carr","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2018.03.032_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","article-title":"Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis","volume":"92","author":"Ronnett","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.03.032_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.pas.0000202039.74837.7d","article-title":"Pseudomyxoma peritonei of appendiceal origin: a clinicopathological analysis of 101 patients uniformly treated at a single institution, with literature review","volume":"30","author":"Bradley","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"20","key":"10.1016\/j.ejso.2018.03.032_bib11","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.03.032_bib12","article-title":"Validation of the recent PSOGI pathological classification of pseudomyxoma peritonei in a single-center series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","author":"Baratti","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.032_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1477-7819-6-118","article-title":"Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin\/fluorouracil\/leucovorin (FOLFOX4)","volume":"6","author":"Chen","year":"2008","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2018.03.032_bib14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5858\/134.6.864","article-title":"Appendiceal mucinous neoplasms: controversial issues","volume":"134","author":"Misdraji","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejso.2018.03.032_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1155\/2012\/163284","article-title":"Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2018.03.032_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","article-title":"Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases","volume":"65","author":"Carr","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.ejso.2018.03.032_bib17","series-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas","article-title":"Pseudomyxoma peritonei and peritoneal metastases from appendiceal malignancy","author":"Sugarbaker","year":"2012"},{"issue":"1","key":"10.1016\/j.ejso.2018.03.032_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.20038","article-title":"Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process","volume":"86","author":"Mohamed","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.03.032_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2015.12.012","article-title":"Prognostic molecular subtypes of low-grade cancer of the appendix","volume":"222","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2018.03.032_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/gm559","article-title":"Genome- wide mutational landscape of\u00a0mucinous carcinomatosis peritonei of appendiceal origin","volume":"6","author":"Alakus","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.ejso.2018.03.032_bib21","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1002\/ijc.29245","article-title":"Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry","volume":"136","author":"Nummela","year":"2015","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.ejso.2018.03.032_bib22","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/bjs.9674","article-title":"Peritoneal Surface Oncology Group International (PSOGI). Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"101","author":"Kusamura","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2018.03.032_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","article-title":"Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy","volume":"6","author":"Sugarbaker","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2018.03.032_bib24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumors","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.032_bib25","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2018.03.032_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PAS.0b013e31817ec31e","article-title":"Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms","volume":"33","author":"Yantiss","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2018.03.032_bib27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/bjs.8739","article-title":"Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms","volume":"99","author":"McDonald","year":"2012","journal-title":"Br J Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318310023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318310023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:27:14Z","timestamp":1760059634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318310023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0748798318310023"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.03.032","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}